Navigation Links
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
Date:6/3/2008

XIAFLEX also Meets Primary Endpoint (p<0.001) in Australian CORD II Phase

III Study Pharmacokinetic Study Demonstrates Lack of Systemic Exposure of XIAFLEX Serious Adverse Events Occurring at a 0.33% Rate per XIAFLEX injection Conference call scheduled for today, June 3, at 8:45 a.m. Eastern Time

MALVERN, Pa., June 3 /PRNewswire-FirstCall/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced positive top-line efficacy and safety results from the CORD I and CORD II phase III clinical trials for XIAFLEX(TM) (clostridial collagenase for injection) in the treatment of Dupuytren's contracture. Each of the CORD I and II trials successfully met the primary endpoint, a reduction in the angle of a patient's joint contracture to

"We believe that this is a great day for the patients who suffer from Dupuytren's contracture, the physicians who treat the disease, and Auxilium, as XIAFLEX appears
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
3. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
4. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
5. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
6. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
7. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
8. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
9. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
10. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
11. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...BRUNSWICK, N.J., Nov. 25 Swissray ...ct digital Radiography ( ddR ) systems, announced ...private Swiss Investor with a long term view towar...cquisition included all assets and intellectual pr...25 years of success and growth Swissray is now poi...
(Date:11/25/2009)...W YORK, Nov. 25 Reportlinker.com a...lable in its catalogue: ,, Pain Management - .../p0164220/Pain-Management---Global-Trends.html ,...gence of pain management clinics, and the advent o... the pain management market. Healthcare reforms an...
(Date:11/25/2009)...VIEW, Calif., Nov. 25 ChemoCentr...al data from the Company,s PROTECT-1 (the Prospect...disease Trial) of Traficet-EN(TM) (CCX282-B) in pa...onstrated clinical efficacy with a favorable safet...d evidence of clinical efficacy in the reduction o...
Breaking Medicine Technology:Swissray International Announces New Ownership 2Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Acupuncture Career Guide Launches on Natural Healers 58539 1Acupuncture Career Guide Launches on Natural Healers 58539 2Acupuncture Career Guide Launches on Natural Healers 58539 3Ann Taylor Supports The Fight Against Breast Cancer 58535 1Ann Taylor Supports The Fight Against Breast Cancer 58535 2Sport Science Lab Maintains That Injury to USC Football Player is Symptomatic of the Dangers of Conventional Weight Training 58530 1Sport Science Lab Maintains That Injury to USC Football Player is Symptomatic of the Dangers of Conventional Weight Training 58530 2
...ings, one of the tools used to prevent deep vein t...n incorrectly fitted, putting patients at,risk for...archers at,Presbyterian Hospital of Dallas., Thei...erican Journal of,Nursing., Immobile patients are...ecause blood tends to pool and coagulate in statio...
...als (, http://www.addrenex.com ) has made three s...dentifying and developing as many new drug candida...t-paced timeline they have set for drug discovery ...ng two new drugs, Clonicel(R) for,attention defici...sion,over the past two years. A new drug applicati...
Other Medicine Technology:Dallas Researchers Find Compression Stockings Improperly Used 2Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 2Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 3
(Date:11/27/2009)...ilingual coloring books designed for children ages...ty to educate - inform parents and children alike ...osuars to ABC,S and a host of other topics. , ...ber 27, 2009 -- Today’s children have enough...y hour of the day, but one of the oldest and simpl...
(Date:11/26/2009)...RNewswire/ -- The diabetes population in the Unite... and annual medical spending on the disease is pro...oday, according to a study published in the Decemb...ng Diabetes ® Program (NCDP), a program of No...om the University of Chicago. ,, According to t...
(Date:11/26/2009)...onal rollercoaster, study finds , , THUR... factor meets the jubilant sports fan. , A new ... who root for the winning team -- enjoy the greate...and victory was in doubt, producing feelings of wo...sgiving weekend as you,re glued to the TV set, wat...
(Date:11/26/2009)...ations announces a highly effective and unconventi...ng to make an economic recovery. , ...s the type of challenge that could send ailing hol... David Benton, business growth expert and author o...; The Rfactor Intensive . “Fear is one of...
(Date:11/25/2009)... Onyx Pharmaceuticals,...mpany will host two investor events in December: ,...9:00 a.m. CT/10:00 a.m. ET ,, Principal inves...ng carfilzomib in relapsed and/or refractory multi...ety of Hematology (ASH) Annual Meeting and Exposit...
Breaking Medicine News(10 mins):Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...le generous rainfall over the weekend brought chee...door activities, a heavy downpour Monday morning w...received 104.7 mm of rain in just four days, much ... family went to India Gate to simply enjoy the wea...
...mia and other conditions related to chronic kidney...k of cardiovascular disease; conversely , heart di...ion and the development of kidney disease, accordi...s and worldwide, according to background informati...
...ing serious note of doctors using advertisements t...e Punjab government Monday asked the state's medic...s . Punjab's medical education and researc...il Act. "The prime object of the medical p...
...tish scientists are developing a flu vaccine that ...lso expected to fight anything from winter flu to ...e new FLU-v vaccine is easier to make and can also...oted Dr Stuart Robinson of the Buckinghamshire com...
...earchers in the United Kingdom have found that pat...disease, have greater arterial stiffness. The res...osteoporosis, a common complication of the respira... disease. Their research results appear in...
... Louis researchers have identified common DNA vari... smallpox vaccination. Most of the eight genetic a...e likelihood of fever after smallpox vaccination. ...nation may also influence fever risk after other l...
Other Medicine News:Health News:Studies Identify Interactions Between Heart Disease, Kidney Disease 2Health News:Premature Vascular and Bone Changes Occur in COPD Patients 2Health News:Premature Vascular and Bone Changes Occur in COPD Patients 3Health News:Genetic Variations Leads to Fever After Smallpox Vaccination 2Health News:Genetic Variations Leads to Fever After Smallpox Vaccination 3
Single Pressure Sensor Intravascular Mikro-Tip Pressure Catheters; SPC-340
Single Pressure Sensor Intravascular Mikro-Tip Pressure Catheters; SPC-330A
Single Pressure Sensor Intravascular Mikro-Tip Pressure Catheters; SPC-320
Dual Pressure Sensor Intravascular Mikro-Tip Pressure Catheters with Lumen; SPC-784A
Medicine Products: